LABCORP HOLDINGS INC. OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax
LABCORP HOLDINGS INC. (LH) reported OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax · last filed 2018-02-27
- LABCORP HOLDINGS INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2016-06-30 was $0.00.
- LABCORP HOLDINGS INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2016-03-31 was $0.00.
- LABCORP HOLDINGS INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2015-12-31 was -$100.00K, a 100.49% decline year-over-year.
- LABCORP HOLDINGS INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2015-09-30 was $0.00.
- LABCORP HOLDINGS INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for fiscal 2017 was $0.00.
- LABCORP HOLDINGS INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for fiscal 2016 was $0.00.
- LABCORP HOLDINGS INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for fiscal 2015 was -$100.00K, a 105.00% decline from fiscal 2014.
- LABCORP HOLDINGS INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for fiscal 2014 was $2.00M, a 87.80% decline from fiscal 2013.
| Period end | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 3 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 3 month as first filed | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 6 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 9 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 12 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 12 month as first filed |
|---|---|---|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-02-27 | |||||
| 2016-12-31 | $0.00 10-K · filed 2018-02-27 | |||||
| 2016-06-30 | $0.00 10-Q · filed 2016-07-29 | $0.00 10-Q · filed 2016-07-29 | -$100.00K derived: sum of 3 quarters · filed 2018-02-27 | -$100.00K derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-06 | -$100.00K derived: sum of 2 quarters · filed 2018-02-27 | -$100.00K derived: sum of 3 quarters · filed 2018-02-27 | -$100.00K derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2015-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$100.00K derived: sum of 2 quarters · filed 2018-02-27 | -$100.00K derived: sum of 3 quarters · filed 2018-02-27 | -$100.00K 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $0.00 10-Q · filed 2015-10-30 | $0.00 derived: sum of 2 quarters · filed 2016-07-29 | $0.00 10-Q · filed 2015-10-30 | $20.30M derived: sum of 4 quarters · filed 2017-02-27 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-07-29 | -$100.00K 10-Q · filed 2016-07-29 | $20.30M derived: sum of 3 quarters · filed 2017-02-27 | $18.30M derived: sum of 4 quarters · filed 2017-02-27 | ||
| 2015-03-31 | -$100.00K 10-Q · filed 2016-05-06 | $20.30M derived: sum of 2 quarters · filed 2017-02-27 | $18.30M derived: sum of 3 quarters · filed 2017-02-27 | $2.50M derived: sum of 4 quarters · filed 2017-02-27 | ||
| 2014-12-31 | $20.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $18.40M derived: sum of 2 quarters · filed 2017-02-27 | $2.60M derived: sum of 3 quarters · filed 2017-02-27 | $2.00M 10-K · filed 2017-02-27 | -$16.30M 10-K · filed 2015-02-26 | |
| 2014-09-30 | -$2.00M 10-Q · filed 2015-10-30 | -$17.80M derived: sum of 2 quarters · filed 2015-10-30 | -$18.40M 10-Q · filed 2015-10-30 | -$17.70M derived: sum of 4 quarters · filed 2017-02-27 | ||
| 2014-06-30 | -$15.80M 10-Q · filed 2015-07-30 | -$16.40M 10-Q · filed 2015-07-30 | -$15.70M derived: sum of 3 quarters · filed 2017-02-27 | -$15.70M derived: sum of 4 quarters · filed 2017-02-27 | ||
| 2014-03-31 | -$16.30M 10-K · filed 2017-02-27 | -$600.00K 10-Q · filed 2014-04-29 | $100.00K derived: sum of 2 quarters · filed 2017-02-27 | $100.00K derived: sum of 3 quarters · filed 2017-02-27 | $100.00K derived: sum of 4 quarters · filed 2017-02-27 | |
| 2013-12-31 | $16.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $16.40M derived: sum of 2 quarters · filed 2016-03-01 | $16.40M derived: sum of 3 quarters · filed 2016-03-01 | $16.40M 10-K · filed 2016-03-01 | ||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $0.00 10-Q · filed 2014-11-10 | |||
| 2013-06-30 | $0.00 10-Q · filed 2014-07-29 | $0.00 10-Q · filed 2014-07-29 | ||||
| 2013-03-31 | $0.00 10-Q · filed 2014-04-29 | |||||
| 2012-12-31 | $0.00 10-K · filed 2015-02-26 | |||||
| 2011-12-31 | $0.00 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |